The Claim
After discontinuation of colchicine at six months, the mean monthly rate of gout flares in patients previously treated with colchicine is not significantly different from the mean monthly rate of gout flares in patients previously treated with placebo over a 12-month period.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients who stopped taking colchicine after six months had the same number of gout flares per month as those who took a placebo, over a 12-month period.
See the scientific wording
After discontinuation of colchicine at six months, the rate of gout flares in patients who initially received colchicine rises to match that of patients who received placebo, with no significant difference in mean monthly flare rates between groups over a 12-month period.
Colchicine blocks the movement of white blood cells called neutrophils into joints when uric acid crystals are present. This stops the inflammation that causes pain and swelling. Once colchicine is stopped, neutrophils can move into the joints again and trigger flares just like before treatment started.
What the research says
1 studyWhen people took colchicine for 6 months, they had fewer gout flares, but once they stopped taking it, their flare rate went back up to the same level as people who never took the drug. So the medicine only works while you're taking it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.